297 related articles for article (PubMed ID: 25652327)
21. Universal tumor screening for Lynch syndrome: Assessment of the perspectives of patients with colorectal cancer regarding benefits and barriers.
Hunter JE; Zepp JM; Gilmore MJ; Davis JV; Esterberg EJ; Muessig KR; Peterson SK; Syngal S; Acheson LS; Wiesner GL; Reiss JA; Goddard KA
Cancer; 2015 Sep; 121(18):3281-9. PubMed ID: 26036338
[TBL] [Abstract][Full Text] [Related]
22. [Familial non-polyposis colorectal carcinoma (Lynch syndrome) in Germany - analysis of information, advisory service and family screening].
Schneider R; Rümmele P; Dechant S; Hofstädter F; Lorenz W; Fürst A
Dtsch Med Wochenschr; 2011 Jan; 136(1-2):17-22. PubMed ID: 21181610
[TBL] [Abstract][Full Text] [Related]
23. Sharing genetic test results in Lynch syndrome: communication with close and distant relatives.
Stoffel EM; Ford B; Mercado RC; Punglia D; Kohlmann W; Conrad P; Blanco A; Shannon KM; Powell M; Gruber SB; Terdiman J; Chung DC; Syngal S
Clin Gastroenterol Hepatol; 2008 Mar; 6(3):333-8. PubMed ID: 18258490
[TBL] [Abstract][Full Text] [Related]
24. Perceptions of cancer risks and predictors of colon and endometrial cancer screening in women undergoing genetic testing for Lynch syndrome.
Hadley DW; Jenkins JF; Steinberg SM; Liewehr D; Moller S; Martin JC; Calzone KA; Soballe PW; Kirsch IR
J Clin Oncol; 2008 Feb; 26(6):948-54. PubMed ID: 18281669
[TBL] [Abstract][Full Text] [Related]
25. Screening and preventive behaviors one year after predictive genetic testing for hereditary nonpolyposis colorectal carcinoma.
Collins V; Meiser B; Gaff C; St John DJ; Halliday J
Cancer; 2005 Jul; 104(2):273-81. PubMed ID: 15948171
[TBL] [Abstract][Full Text] [Related]
26. Population-based molecular screening for Lynch syndrome: implications for personalized medicine.
Ward RL; Hicks S; Hawkins NJ
J Clin Oncol; 2013 Jul; 31(20):2554-62. PubMed ID: 23733757
[TBL] [Abstract][Full Text] [Related]
27. The histomorphology of Lynch syndrome-associated ovarian carcinomas: toward a subtype-specific screening strategy.
Chui MH; Ryan P; Radigan J; Ferguson SE; Pollett A; Aronson M; Semotiuk K; Holter S; Sy K; Kwon JS; Soma A; Singh N; Gallinger S; Shaw P; Arseneau J; Foulkes WD; Gilks CB; Clarke BA
Am J Surg Pathol; 2014 Sep; 38(9):1173-81. PubMed ID: 25025451
[TBL] [Abstract][Full Text] [Related]
28. Development of colorectal tumors in colonoscopic surveillance in Lynch syndrome.
Mecklin JP; Aarnio M; Läärä E; Kairaluoma MV; Pylvänäinen K; Peltomäki P; Aaltonen LA; Järvinen HJ
Gastroenterology; 2007 Oct; 133(4):1093-8. PubMed ID: 17919485
[TBL] [Abstract][Full Text] [Related]
29. Uptake of genetic testing by relatives of lynch syndrome probands: a systematic review.
Sharaf RN; Myer P; Stave CD; Diamond LC; Ladabaum U
Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1093-100. PubMed ID: 23669308
[TBL] [Abstract][Full Text] [Related]
30. Mismatch repair protein immunohistochemistry: a useful population screening strategy for Lynch syndrome.
Musulén E; Sanz C; Muñoz-Mármol AM; Ariza A
Hum Pathol; 2014 Jul; 45(7):1388-96. PubMed ID: 24768606
[TBL] [Abstract][Full Text] [Related]
31. Communicating cancer risk within an African context: experiences, disclosure patterns and uptake rates following genetic testing for Lynch syndrome.
Bruwer Z; Futter M; Ramesar R
Patient Educ Couns; 2013 Jul; 92(1):53-60. PubMed ID: 23453851
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of Lynch syndrome in a Middle Eastern population with colorectal cancer.
Siraj AK; Prabhakaran S; Bavi P; Bu R; Beg S; Hazmi MA; Al-Rasheed M; Al-Assiri M; Sairafi R; Al-Dayel F; Al-Sanea N; Uddin S; Al-Kuraya KS
Cancer; 2015 Jun; 121(11):1762-71. PubMed ID: 25712738
[TBL] [Abstract][Full Text] [Related]
33. Family-based screening for colorectal cancer: The Australian perspective.
Leggett BA
J Gastroenterol Hepatol; 2009 Oct; 24 Suppl 3():S29-32. PubMed ID: 19799695
[TBL] [Abstract][Full Text] [Related]
34. Lethal privacy: Quantifying life years lost if the right to informational self-determination guides genetic screening for Lynch syndrome.
Gansen F; Severin F; Schleidgen S; Marckmann G; Rogowski W
Health Policy; 2019 Oct; 123(10):1004-1010. PubMed ID: 31492458
[TBL] [Abstract][Full Text] [Related]
35. Surveillance on mutation carriers of DNA mismatch repair genes.
Järvinen HJ; Aarnio M
Ann Chir Gynaecol; 2000; 89(3):207-10. PubMed ID: 11079789
[TBL] [Abstract][Full Text] [Related]
36. Direct contact in inviting high-risk members of hereditary colon cancer families to genetic counselling and DNA testing.
Aktan-Collan K; Haukkala A; Pylvänäinen K; Järvinen HJ; Aaltonen LA; Peltomäki P; Rantanen E; Kääriäinen H; Mecklin JP
J Med Genet; 2007 Nov; 44(11):732-8. PubMed ID: 17630403
[TBL] [Abstract][Full Text] [Related]
37. Uptake of genetic testing by the children of Lynch syndrome variant carriers across three generations.
Seppälä TT; Pylvänäinen K; Mecklin JP
Eur J Hum Genet; 2017 Nov; 25(11):1237-1245. PubMed ID: 28832568
[TBL] [Abstract][Full Text] [Related]
38. Initiation of universal tumor screening for Lynch syndrome in colorectal cancer patients as a model for the implementation of genetic information into clinical oncology practice.
Cohen SA; Laurino M; Bowen DJ; Upton MP; Pritchard C; Hisama F; Jarvik G; Fichera A; Sjoding B; Bennett RL; Naylor L; Jacobson A; Burke W; Grady WM
Cancer; 2016 Feb; 122(3):393-401. PubMed ID: 26480326
[TBL] [Abstract][Full Text] [Related]
39. Risk of cancer in individuals with Lynch-like syndrome and their families: a systematic review.
Nugroho PP; Ghozali SAS; Buchanan DD; Pisano MI; Reece JC
J Cancer Res Clin Oncol; 2023 Jan; 149(1):25-46. PubMed ID: 36251064
[TBL] [Abstract][Full Text] [Related]
40. Colorectal cancer due to deficiency in DNA mismatch repair function: a review.
Bellizzi AM; Frankel WL
Adv Anat Pathol; 2009 Nov; 16(6):405-17. PubMed ID: 19851131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
